SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016837
Filing Date
2019-11-12
Accepted
2019-11-12 08:31:20
Documents
65
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 461480
2 ex31-1.htm EX-31.1 11807
3 ex31-2.htm EX-31.2 11805
4 ex32-1.htm EX-32.1 10613
  Complete submission text file 0001493152-19-016837.txt   3674937

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20190930.xml EX-101.INS 635155
6 XBRL SCHEMA FILE cocp-20190930.xsd EX-101.SCH 44863
7 XBRL CALCULATION FILE cocp-20190930_cal.xml EX-101.CAL 59802
8 XBRL DEFINITION FILE cocp-20190930_def.xml EX-101.DEF 208873
9 XBRL LABEL FILE cocp-20190930_lab.xml EX-101.LAB 340185
10 XBRL PRESENTATION FILE cocp-20190930_pre.xml EX-101.PRE 281752
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 191206358
SIC: 2834 Pharmaceutical Preparations